
Gosset, Inc.
Drug intelligence from clinical evidence database for competitive analysis, trial design, and biotech due diligence.
Overview
Gosset is an advanced drug intelligence platform purpose-built for the life sciences industry. It enables biotech and pharmaceutical teams to generate competitive landscapes, head-to-head comparisons, trial design benchmarks, and due diligence reports — all powered by what the company describes as the most comprehensive clinical evidence database in biotech.
Gosset serves organizations that need to make faster, more confident decisions across research, business development, and strategy functions. The platform is built by a team with deep expertise in both artificial intelligence and life sciences, including co-founders who previously served as Directors of AI at Clario and conducted research at Stanford University.
Core Data Coverage
- Coverage of more than 100,000 drugs across the development landscape
- Data on over 120,000 companies operating in the life sciences space
- More than 23,000 biological targets indexed for research and competitive analysis
- A database of over 1 million clinical trials and 400,000 trial results
- More than 100,000 deals tracked for due diligence and business development use cases
Key Use Cases and Capabilities
- Competitive landscape generation to understand the positioning of drugs and programs within a therapeutic area
- Head-to-head comparisons of drugs, targets, or clinical programs
- Trial design benchmarking to inform protocol development and strategic planning
- Due diligence reports to support investment and partnership decisions
- Rapid decision support for teams evaluating biotech opportunities
Team and Advisory Network
- Co-founded by Lukas Kidzinski, former Director of AI at Clario and Stanford University researcher, and Kevin Thomas, former Director of AI at Clario and Stanford University PhD
- Advised by Scott Delp, Professor of Bioengineering at Stanford University
- Dan Gebow, CEO at Recombo.ai and former SVP of Product at Oracle Life Sciences, serves as an advisor
- Robert Bogucki, Director at Google and former CEO of deepsense.ai, is both an advisor and investor
Gosset offers product demonstrations through a 15-minute walkthrough tailored to specific use cases, and provides ongoing product information, feature updates, and biotech insights to prospective users and customers.